Clinical Trial Update: The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous immunoglobulin therapy for treatment-induced diabetic neuropathy was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Diabetes Complications, Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2023-09-13